Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Advanced Pharma - Miami, Miami, Florida Omega Research Group, Orlando, Florida Sonar Clinical Research, Riverdale, Georgia Neuro-Behavioral Clinical Research, North Canton, Ohio University of Texas Health Science Center Houston, Houston, Texas Worldwide Clinical Trials, San Antonio, Texas